Aryeh Jason 4

What Happened

• Aryeh Jason, a director of Orchestra BioMed Holdings, Inc. (OBIO), received an award of 42,553 derivative securities (reported as a grant/award) on 2026-06-23. The filing reports an acquisition price of $0.00 per share (total reported value $0.00). The footnote clarifies these are stock options that vest on the one-year anniversary of the June 23, 2026 grant, subject to continuous service.

Key Details

• Transaction date: 2026-06-23; Form 4 filed: 2026-06-25 (timely).
• Transaction type/code: Grant/Award of derivative securities (Code A).
• Quantity: 42,553 derivative shares; reported price: $0.00 per share.
• Vesting: Options vest on 2027-06-23 (one-year cliff), subject to continued service (per footnote).
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Not marked late.

Context

• This was a grant of stock options (a compensation award), not a market purchase or sale — no exercise or immediate sale occurred. Grants to directors are a common form of compensation and do not, by themselves, indicate the insider’s view of the stock.